Czech National Bank Buys 2,619 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Czech National Bank boosted its holdings in The Cooper Companies, Inc. (NASDAQ:COOFree Report) by 6.5% during the 4th quarter, Holdings Channel reports. The firm owned 43,181 shares of the medical device company’s stock after acquiring an additional 2,619 shares during the period. Czech National Bank’s holdings in Cooper Companies were worth $3,970,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also bought and sold shares of COO. Point72 Asset Management L.P. boosted its position in Cooper Companies by 480.1% in the second quarter. Point72 Asset Management L.P. now owns 937,806 shares of the medical device company’s stock worth $81,870,000 after purchasing an additional 776,140 shares during the last quarter. Victory Capital Management Inc. lifted its position in shares of Cooper Companies by 23.0% during the 3rd quarter. Victory Capital Management Inc. now owns 3,950,119 shares of the medical device company’s stock valued at $435,856,000 after buying an additional 737,726 shares during the last quarter. Magnetar Financial LLC purchased a new position in shares of Cooper Companies during the 2nd quarter valued at $63,822,000. JPMorgan Chase & Co. lifted its position in shares of Cooper Companies by 13.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 4,930,022 shares of the medical device company’s stock valued at $543,979,000 after buying an additional 573,908 shares during the last quarter. Finally, International Assets Investment Management LLC purchased a new position in shares of Cooper Companies during the 3rd quarter valued at $46,727,000. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on COO shares. Citigroup dropped their price target on Cooper Companies from $116.00 to $115.00 and set a “buy” rating on the stock in a research report on Friday, December 6th. Morgan Stanley dropped their price target on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a research report on Friday, December 6th. StockNews.com cut Cooper Companies from a “buy” rating to a “hold” rating in a research report on Wednesday, December 11th. Wells Fargo & Company increased their price objective on Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a report on Friday, December 6th. Finally, Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a report on Friday, December 6th. Four research analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $117.00.

Check Out Our Latest Stock Report on Cooper Companies

Cooper Companies Price Performance

Shares of NASDAQ COO opened at $90.68 on Thursday. The firm has a market capitalization of $18.10 billion, a P/E ratio of 46.50, a P/E/G ratio of 2.40 and a beta of 0.99. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The stock’s 50-day simple moving average is $97.24 and its two-hundred day simple moving average is $98.95. The Cooper Companies, Inc. has a twelve month low of $84.76 and a twelve month high of $112.38.

Cooper Companies (NASDAQ:COOGet Free Report) last announced its earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share for the quarter, topping analysts’ consensus estimates of $1.00 by $0.04. The business had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.03 billion. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The company’s quarterly revenue was up 9.8% compared to the same quarter last year. During the same period in the prior year, the company earned $0.87 EPS. As a group, equities analysts anticipate that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

About Cooper Companies

(Free Report)

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

Further Reading

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COOFree Report).

Institutional Ownership by Quarter for Cooper Companies (NASDAQ:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.